A statistically significant survival difference was found between the PSG+ and PSG− groups in uterine cancer with a log-rank p of 0.0138 and borderline significance in kidney cancer with a log-rank p of 0.0746 ( Supplemental Fig. 3 ).
← all excerpts
Pregnancy-specific glycoproteins as potential drug targets for female lung adenocarcinoma patients.
1
—
—